Annual Report Index

  • Frontpage
  •  
  • Who we are
  •  
  • How we perform
  •  
  • How we are accountable
  •  
  • Downloads
  • About Novo Nordisk
  • Management
  • Governance
  • Ownership
  • Facts and figures
  • Vision and strategy
  • Novo Nordisk Way of Management
  • Triple Bottom Line
  • Stakeholder engagement
  • Welcome letter
  • Annual Report Index
  • Rate this page
  • Send to a friend
  • Print

Annual Report Index

Are you looking for specific information and do not immediately find it, this index might be of help:

Topic of interest

A
About Novo Nordisk
Access to health
Accountability
Advocacy
Animal welfare
Audit and assurance
Awards and recognitions
B
Board of Directors
Brand and reputation management
Business ethics
Business strategy
C
Capital structure
Changing diabetes
Clinical trials
Community engagement
Compliance
Corporate governance
D
Definitions
Diabetes care
Diversity
Donations
E
Economic footprint
Environment
Executive Management
F
Financial performance
G
Gene technology
Global Compact
Global Reporting Initiative (GRI)
H
Health and safety
Human rights
L
Legal issues
M
Materiality
Memberships
N
Novo Nordisk Way of Management
P
Partnerships
People strategy
Pipeline
Product stewardship
Q
Quality
R
Remuneration
Responsible sourcing
Risk management
S
Share information
Social responsibility
Socio-economics
Stakeholder engagement
Stem cell research
Sustainability
T
Talent development
Tax
Triple Bottom Line
W
Workplace quality
Back to top
 
  • Novo Nordisk in the USA
  • Novo Nordisk in Denmark
  • Global Offices
  • Novo A/S
  • Novozymes
  • Disclaimer/Privacy
  • © Novo Nordisk A/S 2009